Company / Revenue per Share
Upstream Bio, Inc. Revenue per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.05
FY2025
5-year range
$0.05 / $0.81
FY2023-FY2025
Trend
-93.3%
vs FY2024
Sector context
#140 of 154
Health Care
What the data says
Among 154 Health Care companies, Upstream Bio, Inc. is in the bottom 9% for revenue per share. Declined from $0.81 to $0.05 over the past 2 years.
Based on SEC 10-K filings.
0.05 in FY2025.
Declined from $0.81 to $0.05 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 154This company $0.05 Sector average $15.09
▼
-99.6% below sector average
Key checks
Key Insights
- In FY2025, revenue per share decreased 93.3% year-over-year.
- Ranks #140 out of 154 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 8.68 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.05 | -93.3% |
| FY2024 | $0.80 | -1.3% |
| FY2023 | $0.81 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026